Regenerative Medicine for Hip Osteoarthritis Options

Regenerative Medicine for Hip Osteoarthritis: An Integrative Approach to Pain and Function

Abstract

Hip osteoarthritis (OA) is a significant and growing global health concern, with its prevalence and impact on quality of life steadily increasing. This post explores the rising burden of hip OA, exploring its anatomy, clinical presentation, and the profound effects it has on overall health, including an increased risk of all-cause and cardiovascular mortality. I will review the standard diagnostic exams and discuss conventional treatment options, highlighting their limitations. Furthermore, I will present the latest evidence-based findings on biologic therapies such as Platelet-Rich Plasma (PRP), comparing their efficacy and long-term benefits with traditional corticosteroid injections. Using a clinical case study, I will illustrate how these advanced regenerative treatments, when combined with a foundational integrative chiropractic care and physical rehabilitation plan, can offer lasting relief and restore function, providing a comprehensive strategy for managing this debilitating condition.

The Growing Global Burden of Hip Osteoarthritis

As a clinician with a diverse background spanning chiropractic, nursing, and functional medicine, I am deeply invested in understanding the root causes of conditions that significantly impact my patients’ lives. Hip osteoarthritis (OA) is one such condition that I see with increasing frequency in my practice. While we feel like we see it often, the data confirm that this is not just an anecdotal observation; it’s a serious and growing global health issue.

The Global Burden of Disease Study, a massive undertaking that has tracked hundreds of diseases for decades, provides sobering statistics. In their 2019 analysis covering 200 countries, researchers found that between 1990 and 2019, the global incidence of hip OA more than doubled, soaring from approximately 740,000 cases to 1.6 million.

When we examine the geographical distribution of these cases, a distinct pattern emerges. High-income regions, particularly in North America, show the highest rates. This trend suggests that economic factors and perhaps activity levels associated with certain lifestyles may play a role in the development of the disease. What is truly alarming is that this upward trend is nearly universal; even countries that had the lowest incidence rates in 1990 have seen a steady rise.

This isn’t just about joint pain. The impact of hip OA extends far beyond the joint itself, affecting a person’s entire well-being. The condition often leads to a significant reduction in physical activity, which in turn creates a cascade of other health problems. Metrics such as Disability-Adjusted Life Years (DALYs), which measure overall disease burden, continue to rise for hip OA.

Stunningly, research shows that symptomatic arthritis of the knee and hip is associated with a 20% higher age-adjusted mortality rate. A 2015 study with a 16-year follow-up period quantified this risk even more precisely, revealing that a diagnosis of hip OA increased:

• All-cause mortality by 14%
• Cardiovascular disease mortality by 24%

These figures underscore a critical point: managing hip OA is not just about alleviating pain. It is about addressing a condition that literally poses a hazard to a patient’s longevity and overall health. The reduction in activity is a burden that has real, measurable, and life-altering consequences.

The Complex Anatomy of the Hip Region

To truly understand hip pain, we must first appreciate the intricate architecture of the hip and pelvis. It’s a marvel of biomechanical engineering, but its complexity also means there are numerous potential sources of pain.

Bony and Joint Structures

The core of the hip joint is the articulation between the femur (thigh bone) and the acetabulum (the socket in the pelvis). This ball-and-socket joint is designed for a wide range of motion and stability. Other crucial bony landmarks include:

• The greater trochanter, a prominent bony point on the side of the hip where key muscles, like the gluteus medius and minimus, attach.
• The sacroiliac (SI) joint, which connects the pelvis to the spine and can often be a confounding source of pain that mimics hip issues.

The C-Sign and Common Pain Patterns

When a patient has true intra-articular hip joint pathology, the clinical presentation is often quite specific. They typically describe a sharp, pinching pain, most commonly felt in the anterior groin and inner thigh. A classic indicator is the “C-sign,” where a patient cups their hand in a “C” shape around the side of their hip to show you where it hurts.

We can map out the common pain distributions:

• Anterior Hip Pain (Blue Area): Most commonly associated with problems within the hip joint itself.
• Lateral Hip Pain (Red Area): Often related to issues like gluteal tendinopathy or trochanteric bursitis.
• Posterior or Buttock Pain (Green Area): Typically points to the SI joint, piriformis syndrome, or lumbar spine issues.

However, it’s crucial to remember that these are not absolute rules. From my clinical experience, I can tell you that approximately 10% of the time, true hip joint pathology can present with exclusively posterior pain. If you are treating a patient for what appears to be an SI joint or hamstring issue and they are not improving, it is essential to investigate the hip joint itself. It is remarkably easy to overlook small bone spurs or subtle degenerative changes, even on an MRI.

The Clinical Examination: Putting the Pieces Together

A thorough physical exam is paramount for an accurate diagnosis. While we look at standard ranges of motion, for the hip joint, assessing internal and external rotation is particularly revealing. A healthy hip typically has around 30-40 degrees of internal rotation and 40-60 degrees of external rotation.

Several orthopedic tests help us pinpoint the source of pain:

• Log Roll Test: A very specific test where the examiner passively rolls the patient’s leg internally and externally. Pain with this gentle maneuver is highly indicative of an intra-articular hip problem.
• FABER Test (Flexion, ABduction, External Rotation): This test places the hip in a “figure-4” position. While it is excellent for provoking hip joint pain, it can also stress the SI joint. Therefore, I always ask the patient, “Where are you feeling this pain?” to differentiate the source.
• FADIR Test (Flexion, ADduction, Internal Rotation): This is perhaps our most useful test for identifying hip impingement and labral pathology. Even if it reproduces pain in a lateral or posterior location, a positive test in a patient with high suspicion for hip pathology keeps the joint at the top of my differential diagnosis.

Foundational Treatment: The Non-Negotiable Role of Rehabilitation

Before we even discuss injections or more advanced interventions, I want to emphasize a core principle: physical therapy, physical therapy, and more physical therapy. This is the absolute foundation of any successful hip treatment plan.

The reason we reviewed the anatomy is to understand that the hip joint does not function in isolation. It is the central pillar, but the vast network of muscles surrounding it is directly integrated with its function and stability. You can perform the most precise, effective injection in the world, but if the patient’s underlying biomechanics are faulty and the supporting musculature is weak or imbalanced, the pain will inevitably return. The treatment will not provide long-term benefit.

This is where integrative chiropractic care plays an indispensable role. As a chiropractor, my focus is on restoring proper joint mechanics —not just in the hip, but throughout the entire kinetic chain, from the lumbar spine and pelvis down to the feet. By using targeted adjustments, soft-tissue therapies, and postural correction, we can address the biomechanical dysfunctions that contribute to the overloading of the hip joint. This creates an optimal environment for healing and ensures that the benefits of any other therapies are maximized and sustained.

A Critical Look at Injection Therapies

When conservative care is not enough, injections are often the next step. Let’s look at the evidence for the most common options.

Corticosteroid Injections

Corticosteroids have long been a mainstay for managing inflammatory joint pain. Guided by ultrasound or fluoroscopy, these injections can be used for both therapeutic pain relief and diagnostic purposes (i.e., if the pain disappears after the injection, it confirms the joint as the source).

Major medical societies, such as the American Academy of Orthopedic Surgeons, give this treatment a moderate recommendation for short-term pain reduction. But what does “short-term” really mean?

A 2021 systematic review published in the British Journal of Sports Medicine analyzed 16 randomized controlled trials involving over 1,700 patients (Reiman et al., 2021). The findings were clear:

• Steroid injections were significantly more effective than a placebo at the 3-month mark.
• However, by 6 months, there was no significant difference in pain relief compared to the placebo.

The conclusion is that while corticosteroids can provide a valuable, temporary window of pain relief, they are not a long-lasting solution for chronic hip OA.

Platelet-Rich Plasma (PRP)

This brings us to the exciting field of biologics, specifically Platelet-Rich Plasma (PRP). PRP is a concentration of a patient’s own platelets, derived from a simple blood draw. These platelets contain a powerful cocktail of growth factors and signaling proteins that can help modulate inflammation, stimulate tissue repair, and potentially slow down the degenerative process.

A pooled analysis of eight randomized controlled trials found that PRP effectively reduced pain at multiple time points (Belk et al., 2021). Interestingly, the review noted:

• A single PRP injection often yielded better results than a series of injections.
• Lower volumes of injectate (less than their cutoff of 15 mL) performed better than higher volumes. This is critical for the hip, which is a tight, low-volume joint. I find that around 5 mL is a comfortable and effective amount. Increasing the volume can be extremely uncomfortable for the patient, regardless of the substance injected.

The Head-to-Head Comparison: Steroids vs. PRP

So, how do these two treatments stack up against each other? A large systematic review and meta-analysis from 2022, which included eleven studies and over 1,000 patients, provided a direct comparison (Nouri et al., 2022). The results were compelling:

• Corticosteroids were effective in the short term, confirming what we already knew.
• PRP provided the most significant reduction in pain at 6 months.

This aligns with the broader body of evidence we have from knee OA studies and reinforces my clinical observations. Biologics like PRP take longer to exert their effects than corticosteroids, but their benefits are significantly more durable. While some studies suggest effects can be seen in 6-8 weeks, we generally counsel patients that it may take three months or more to realize the full benefit.

Clinical Application: A Case Study

Let me share a case from my practice that highlights the complexity of this region and the power of an integrative approach.

I treated a 22-year-old Division I college football linebacker. He came to our program after transferring, with a six-month history of debilitating “back pain.” His previous school had tried multiple epidural steroid injections, a facet branch block, and even a sciatic nerve injection, all with no benefit.

His hip exam was strikingly positive. He had limited internal rotation (only 15 degrees), and his pain was easily reproduced with the FABER test. His lumbar spine exam, ironically, was normal. His previous team had focused entirely on his back, getting an MRI that showed a large L5-S1 disc herniation. But no one had ever properly examined his hip.

We obtained simple AP and frog-leg X-rays of his hips, which revealed a cam-type impingement—a bony overgrowth on the femoral head-neck junction. An MRI confirmed this, along with signs of cartilage degeneration.

Here was our treatment plan:

1. Rehabilitation First: We immediately started him with physical therapy focused on core strengthening and hip-specific motor control to unload the joint.
2. Diagnostic & Therapeutic Injection: Because he was an in-season athlete needing to perform immediately, we performed a diagnostic corticosteroid injection into the hip joint. This eliminated his pain, confirming the hip as the primary pain generator.
3. Regenerative Therapy: After his spring season, about three and a half months later, we performed a PRP injection into the hip joint to provide long-term healing and pain control.
4. Optimized PRP Protocol: Using our benchtop processing system, I developed a precise formulation. From his blood, I prepared a 3 mL sample of PRP and also captured an additional 3 mL of Platelet-Poor Plasma (PPP). This plasma contains a wealth of anti-inflammatory cytokines and other beneficial proteins. By combining these, we delivered a 6 mL injection designed to both reduce inflammation and stimulate long-term repair.

The result? His pain resolved completely. He went on to complete his next three years of college football without any time lost due to his hip or lumbar spine. This case is a powerful reminder of how easily hip pathology can be misdiagnosed as a back problem and how a comprehensive, layered approach is key to success.

Future Directions and Final Thoughts

The evidence for biologics in the hip is growing and becoming more robust. While we have a wealth of data for the knee, we are still refining our protocols for the hip. Key questions we are actively working to answer include:

• What is the optimal platelet dosing? We know lower volumes are better, but can we maximize the platelet concentration within that volume for a more powerful effect?
• What is the ideal frequency of injections? The data currently suggest that a single injection may be superior to multiple injections.
• How can we best utilize plasma concentrates? The basic science on the anti-inflammatory and anti-degenerative proteins in platelet-poor plasma is very promising for long-term joint health.

In my clinic, I am committed to staying at the forefront of these advancements, using systems that enable precise, customizable dosing to deliver the best possible outcomes for my patients.

In summary, hip OA is a complex and serious condition with far-reaching health implications. An effective treatment strategy cannot exist in a vacuum. It requires an accurate diagnosis that looks beyond the obvious, a foundational plan of chiropractic care and physical rehabilitation to restore proper biomechanics, and the judicious use of modern, evidence-based regenerative therapies, such as PRP, to promote lasting healing and functional restoration. By taking this integrative journey with our patients, we can help them move beyond pain and reclaim their active lives.

References

• Belk, J. W., Kraeutler, M. J., Houck, D. A., Goodrich, J. A., Dragoo, J. L., & McCarty, E. C. (2021). Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. The American Journal of Sports Medicine, 49(1), 249–260. https://doi.org/10.1177/0363546520909397
• Nouri, F., Babaee, M., & Kavyani, A. (2022). The comparison of platelet-rich plasma and corticosteroid injections in the treatment of hip osteoarthritis: a systematic review and meta-analysis. Journal of Orthopaedic Surgery and Research, 17(1), 391. https://doi.org/10.1186/s13018-022-03282-4
• Reiman, M. P., Goode, A. P., Cook, C. E., Hölmich, P., & Thorborg, K. (2021). Diagnostic accuracy of clinical tests for the diagnosis of hip femoroacetabular impingement syndrome: a systematic review with meta-analysis. British Journal of Sports Medicine, 55(15), 821–834. https://doi.org/10.1136/bjsports-2020-103233
• Veronese, N., Cereda, E., Maggi, S., Luchini, C., Solmi, M., Smith, T., … & Stubbs, B. (2016). The impact of hip or knee osteoarthritis on the risk of all-cause mortality: a systematic review and meta-analysis of cohort studies. Osteoarthritis and Cartilage, 24(Supplement 1), S295. https://doi.org/10.1016/j.joca.2016.01.537
• Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., … & GBD 2019 Diseases and Injuries Collaborators. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9